Northern Trust Corp reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 1.8% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 9,332,544 shares of the healthcare conglomerate's stock after selling 171,127 shares during the period. UnitedHealth Group makes up approximately 0.7% of Northern Trust Corp's portfolio, making the stock its 19th biggest holding. Northern Trust Corp owned 1.03% of UnitedHealth Group worth $4,887,920,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Brooklyn Investment Group grew its position in UnitedHealth Group by 15.4% during the 1st quarter. Brooklyn Investment Group now owns 6,776 shares of the healthcare conglomerate's stock worth $3,549,000 after purchasing an additional 906 shares during the period. Versor Investments LP acquired a new stake in shares of UnitedHealth Group during the 1st quarter valued at about $734,000. Bretton Capital Management LLC grew its position in shares of UnitedHealth Group by 4.1% during the 1st quarter. Bretton Capital Management LLC now owns 10,200 shares of the healthcare conglomerate's stock valued at $5,342,000 after acquiring an additional 400 shares during the period. Blue Edge Capital LLC grew its position in shares of UnitedHealth Group by 1.2% during the 1st quarter. Blue Edge Capital LLC now owns 16,793 shares of the healthcare conglomerate's stock valued at $8,795,000 after acquiring an additional 192 shares during the period. Finally, Foyston Gordon & Payne Inc grew its position in shares of UnitedHealth Group by 47.4% during the 1st quarter. Foyston Gordon & Payne Inc now owns 44,365 shares of the healthcare conglomerate's stock valued at $23,236,000 after acquiring an additional 14,271 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets
In related news, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer owned 10,398 shares in the company, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.28% of the company's stock.
UnitedHealth Group Stock Up 12.0%
UNH stock opened at $304.02 on Monday. The firm has a market cap of $275.34 billion, a PE ratio of 13.17, a PEG ratio of 1.96 and a beta of 0.43. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The firm's 50 day moving average price is $288.91 and its 200-day moving average price is $395.81. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm's quarterly revenue was up 12.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.80 EPS. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be issued a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.9%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.
Wall Street Analyst Weigh In
A number of research firms have recently commented on UNH. KeyCorp dropped their target price on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 30th. Wall Street Zen cut UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Mizuho lowered their price objective on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a report on Friday, May 16th. Piper Sandler lowered their price objective on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. Finally, Barclays reiterated an "overweight" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $366.52.
Read Our Latest Stock Report on UNH
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.